Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

301
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
301
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

575
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
575
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

463
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
463
Drug Therapy01:28

Drug Therapy

134
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
134
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

581
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
581
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

535
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
535

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations.

Frontiers in immunology·2026
Same author

Genome-wide association mapping and targeted loss of function studies identify <i>Shroom3</i> as a driver of hyperpolyploidy and ventricular dilation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Mitochondrial signatures of infant mesenchymal stem cells predict child adiposity: The Healthy Start Study.

Research square·2026
Same author

Psychosocial support utilization among breast cancer patients experiencing reproductive concerns: A cross-sectional cohort study.

Journal of psychosocial oncology·2025
Same author

Altered Arginine Metabolism in Children Undergoing Fontan Palliation: A Prospective Cohort Study.

Pulmonary circulation·2025
Same author

Widespread Proteomic Changes Observed in a Cohort of Neonates and Infants Undergoing Cardiopulmonary Bypass.

JACC. Advances·2025

Related Experiment Video

Updated: Nov 5, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

1.4K

Psychotropic medications in oncology.

Erin K Biringen1, Emily Cox-Martin2, Sierra Niemiec3

  • 1University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. erin.biringen@cuanschutz.edu.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|May 16, 2021
PubMed
Summary

Oncology providers report mixed comfort prescribing psychotropic medications for cancer patients. Enhancing mental health education and patient access to care can improve prescribing practices.

Keywords:
DepressionOncologyPsychological distressPsychotropic medications

More Related Videos

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.5K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.5K

Related Experiment Videos

Last Updated: Nov 5, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

1.4K
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.5K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.5K

Area of Science:

  • Oncology
  • Psychiatry
  • Medical Education

Background:

  • Psychological distress is prevalent in cancer patients.
  • Oncology providers frequently manage these symptoms with psychotropic medications.

Purpose of the Study:

  • To characterize psychotropic medication prescribing patterns by oncology providers.
  • To assess oncology providers' comfort levels with prescribing these medications.

Main Methods:

  • A cross-sectional survey was administered to oncology providers (doctors, nurse practitioners, physician assistants) at a major academic medical center.
  • The survey collected data on provider demographics, prescribing habits, comfort levels, and influencing factors.

Main Results:

  • 65 oncology providers reported equal comfort and discomfort prescribing psychotropic medications.
  • Benzodiazepines were the most commonly prescribed class (89.2%), while mood stabilizers were least prescribed (4.6%).
  • Barriers included difficulty with mental health referrals and insufficient provider education; improved education and patient resources were identified as solutions.

Conclusions:

  • Oncology providers exhibit balanced comfort and discomfort regarding psychotropic medication prescribing.
  • Increased prescribing comfort can be achieved through enhanced mental health education during training and continuing education.
  • Implementing a clinical pathway for psychotropic prescribing and improving patient access to mental health services are recommended.